...
首页> 外文期刊>Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy >Clinical manifestations and risk factors of community-onset Acinetobacter species pneumonia in Japan; case control study in a single institute in Japan
【24h】

Clinical manifestations and risk factors of community-onset Acinetobacter species pneumonia in Japan; case control study in a single institute in Japan

机译:日本社区发病患病患者临床表现与危险因素; 日本单一研究所的案例控制研究

获取原文
获取原文并翻译 | 示例

摘要

To clarify the etiology, patients' characteristics and risk factors for community-onset AP (Acinetobacter species pneumonia), we conducted this case-control study. We reviewed all patients with community-onset AP at our institute from 2010 until 2018. We defined non-AP group as a control. The patients with non-Acinetobacter spp. pneumonia (non-AP) were randomly selected during the study period without clinical information based on medical records' list among patients with community-onset pneumonia. The age (+/- 2 years) and sex were matched to the patients with community-onset AP, and the ratio was AP: non-AP group = 1: 3. Patients' characteristics, clinical outcomes, pathogens isolated and drug susceptibility were evaluated by comparing AP and non-AP group.
机译:为了澄清社区患者的病因,患者的特征和危险因素(肺杆菌肺炎),我们进行了这种案例对照研究。 我们从2010年到2018年从2010年开始审查了所有患有社区onset AP的患者。我们将非AP组定义为控制。 非传神上的患者SPP。 在研究期间,在没有基于医疗记录的患者中的临床信息期间随机选择肺炎(非AP),患有社区发作肺炎的患者。 年龄(+/- 2岁)和性别与患有社区发作AP的患者相匹配,该比例是AP:非AP组= 1:3。患者的特征,临床结果,分离的病原体和药物易感性 通过比较AP和非AP组来评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号